世界の組織スキャフォールド市場2021年-2025年

◆英語タイトル:Global Tissue Scaffolds Market 2021-2025
◆商品コード:IRTNTR40083
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年3月9日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥287,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥345,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥460,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社は世界の組織スキャフォールド市場規模が、2021年~2025年まで年平均11%成長し、12.0億ドルに達すると予測しています。本調査レポートでは、組織スキャフォールドの世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(天然組織スキャフォールド、合成組織スキャフォールド)分析、顧客状況、地域別状況、企業状況、企業分析などを掲載しております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の組織スキャフォールド市場規模:製品別(天然組織スキャフォールド、合成組織スキャフォールド)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Tissue Scaffolds Market 2021-2025

Technavio has been monitoring the tissue scaffolds market and it is poised to grow by $ 1.20 bn during 2021-2025 progressing at a CAGR of 11% during the forecast period. Our report on tissue scaffolds market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing initiatives and support from public and private healthcare organizations and increasing prevalence of chronic and acute wounds. In addition, increasing initiatives and support from public and private healthcare organizations is anticipated to boost the growth of the market as well.

The tissue scaffolds market analysis includes product segment, application segment and geographical landscapes.

Technavio’s tissue scaffolds market is segmented as below:
By Product
• Natural Tissue Scaffolds
• Synthetic Tissue Scaffolds

By Geographical Landscapes
• North America
• Europe
• Asia
• ROW

By Application
• Musculoskeletal
• Dermatological
• Cardiovascular
• Other Applications

This study identifies the increasing adoption of tissue scaffolds as one of the prime reasons driving the tissue scaffolds market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on tissue scaffolds market covers the following areas:
• Tissue scaffolds market sizing
• Tissue scaffolds market forecast
• Tissue scaffolds market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tissue scaffolds market vendors that include Integra LifeSciences Holdings Corp., Medtronic Plc, Merck KGaA, MiMedx Group Inc., Nuvasive Inc., Organogenesis Inc., RTI Surgical Holdings Inc., Smith & Nephew plc, Stryker Corp., and Thermo Fisher Scientific Inc.. Also, the tissue scaffolds market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/tissue-scaffolds-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Natural tissue scaffolds – Market size and forecast 2020-2025
o Synthetic tissue scaffolds – Market size and forecast 2020-2025
o Market opportunity by Product
• Customer landscape
• Market Segmentation by Application
o Musculoskeletal
o Dermatological
o Cardiovascular
o Other applications
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Integra LifeSciences Holdings Corp.
o Medtronic Plc
o Merck KGaA
o MiMedx Group Inc.
o Nuvasive Inc.
o Organogenesis Inc.
o RTI Surgical Holdings Inc.
o Smith & Nephew plc
o Stryker Corp.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Product – Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Natural tissue scaffolds – Market size and forecast 2020-2025 ($ million)
• 24: Natural tissue scaffolds – Year-over-year growth 2020-2025 (%)
• 25: Synthetic tissue scaffolds – Market size and forecast 2020-2025 ($ million)
• 26: Synthetic tissue scaffolds – Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share by geography 2020-2025 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2020-2025 ($ million)
• 32: North America – Year-over-year growth 2020-2025 (%)
• 33: Europe – Market size and forecast 2020-2025 ($ million)
• 34: Europe – Year-over-year growth 2020-2025 (%)
• 35: Asia – Market size and forecast 2020-2025 ($ million)
• 36: Asia – Year-over-year growth 2020-2025 (%)
• 37: ROW – Market size and forecast 2020-2025 ($ million)
• 38: ROW – Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Integra LifeSciences Holdings Corp. – Overview
• 48: Integra LifeSciences Holdings Corp. – Business segments
• 49: Integra LifeSciences Holdings Corp. – Key offerings
• 50: Integra LifeSciences Holdings Corp. – Key customers
• 51: Integra LifeSciences Holdings Corp. – Segment focus
• 52: Medtronic Plc – Overview
• 53: Medtronic Plc – Business segments
• 54: Medtronic Plc – Key offerings
• 55: Medtronic Plc – Key customers
• 56: Medtronic Plc – Segment focus
• 57: Merck KGaA – Overview
• 58: Merck KGaA – Business segments
• 59: Merck KGaA – Key offerings
• 60: Merck KGaA – Key customers
• 61: Merck KGaA – Segment focus
• 62: MiMedx Group Inc. – Overview
• 63: MiMedx Group Inc. – Business segments
• 64: MiMedx Group Inc. – Key offerings
• 65: MiMedx Group Inc. – Key customers
• 66: MiMedx Group Inc. – Segment focus
• 67: Nuvasive Inc. – Overview
• 68: Nuvasive Inc. – Product and service
• 69: Nuvasive Inc. – Key offerings
• 70: Nuvasive Inc. – Key customers
• 71: Nuvasive Inc. – Segment focus
• 72: Organogenesis Inc. – Overview
• 73: Organogenesis Inc. – Business segments
• 74: Organogenesis Inc. – Key offerings
• 75: Organogenesis Inc. – Key customers
• 76: Organogenesis Inc. – Segment focus
• 77: RTI Surgical Holdings Inc. – Overview
• 78: RTI Surgical Holdings Inc. – Business segments
• 79: RTI Surgical Holdings Inc. – Key offerings
• 80: RTI Surgical Holdings Inc. – Key customers
• 81: RTI Surgical Holdings Inc. – Segment focus
• 82: Smith & Nephew plc – Overview
• 83: Smith & Nephew plc – Business segments
• 84: Smith & Nephew plc – Key offerings
• 85: Smith & Nephew plc – Key customers
• 86: Smith & Nephew plc – Segment focus
• 87: Stryker Corp. – Overview
• 88: Stryker Corp. – Business segments
• 89: Stryker Corp. – Key offerings
• 90: Stryker Corp. – Key customers
• 91: Stryker Corp. – Segment focus
• 92: Thermo Fisher Scientific Inc. – Overview
• 93: Thermo Fisher Scientific Inc. – Business segments
• 94: Thermo Fisher Scientific Inc. – Key offerings
• 95: Thermo Fisher Scientific Inc. – Key customers
• 96: Thermo Fisher Scientific Inc. – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations



【掲載企業】

Integra LifeSciences Holdings Corp., Medtronic Plc, Merck KGaA, MiMedx Group Inc., Nuvasive Inc., Organogenesis Inc., RTI Surgical Holdings Inc., Smith & Nephew plc, Stryker Corp., Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の組織スキャフォールド市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆